A comprehensive evaluation of risk factors for mortality, infection and colonization associated with CRGNB in adult solid organ transplant recipients: a systematic review and meta-analysis

References

• Giannella M, Bartoletti M, Conti M, et al. Carbapenemase-producing enterobacteriaceae in transplant patients. J Antimicrob Chemother. 2021;76(Suppl 1):1–11. doi: 10.1093/jac/dkaa495.
   PubMedGoogle Scholar
• Patel G, Perez F, Bonomo RA. Carbapenem-resistant enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation. Curr Opin Organ Transplant. 2010;15(6):676–682. doi: 10.1097/MOT.0b013e3283404373.
   PubMed Web of Science ®Google Scholar
• Kassis-Chikhani N, Saliba F, Carbonne A, et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003–2004. Euro Surveill. 2010;15(46):19713.
   PubMedGoogle Scholar
• Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707. doi: 10.1128/CMR.05035-11.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012. doi: 10.1016/j.jclinepi.2009.06.005.
   PubMed Web of Science ®Google Scholar
• Freire MP, Carvalho LB, Reusing JO, et al. Carbapenem-resistant enterobacteriaceae among kidney transplant recipients – insights on the risk of acquisition and CRE infection. Infect Dis. 2021;53(6):430–439. doi: 10.1080/23744235.2021.1887511.
   PubMed Web of Science ®Google Scholar
• Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101(4):811–820. doi: 10.1097/TP.0000000000001620.
   PubMed Web of Science ®Google Scholar
• Wu D, Chen C, Liu T, et al. Epidemiology, susceptibility, and risk factors associated with mortality in carbapenem-resistant gram-negative bacterial infections among abdominal solid organ transplant recipients: a retrospective cohort study. Infect Dis Ther. 2021;10(1):559–573. doi: 10.1007/s40121-021-00411-z.
   PubMed Web of Science ®Google Scholar
• Cohen Stuart J, Leverstein-Van Hall MA, Dutch Working Party on the Detection of Highly Resistant Microorganisms. Guideline for phenotypic screening and confirmation of carbapenemases in enterobacteriaceae. Int J Antimicrob Agents. 2010;36(3):205–210. doi: 10.1016/j.ijantimicag.2010.05.014.
   PubMed Web of Science ®Google Scholar
• Humphries R, Bobenchik AM, Hindler JA, et al. Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st edition. J Clin Microbiol. 2021;59(12):e0021321.
   PubMed Web of Science ®Google Scholar
• Freire MP, de Oliveira Garcia D, Cury AP, et al. Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients. J Antimicrob Chemother. 2016;71(9):2577–2585. doi: 10.1093/jac/dkw165.
   PubMed Web of Science ®Google Scholar
• Freire MP, Camargo CH, Yamada AY, et al. Critical points and potential pitfalls of outbreak of IMP-1-producing carbapenem-resistant Pseudomonas aeruginosa among kidney transplant recipients: a case–control study. J Hosp Infect. 2021;115:83–92. doi: 10.1016/j.jhin.2021.05.006.
   PubMed Web of Science ®Google Scholar
• Freire MP, Pierrotti LC, Oshiro IC, et al. Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: impact on recipient outcomes. Liver Transpl. 2016;22(5):615–626. doi: 10.1002/lt.24389.
   PubMed Web of Science ®Google Scholar
• Freire MP, Abdala E, Moura ML, et al. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection. 2015;43(3):315–323. doi: 10.1007/s15010-015-0743-4.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang WL, Zhang W, et al. Risk factors and outcomes of carbapenem-resistant Enterobacteriaceae infection after liver transplantation: a retrospective study in a Chinese population. Infect Drug Resist. 2020;13:4039–4045. doi: 10.2147/IDR.S278084.
   PubMed Web of Science ®Google Scholar
• Cinar G, Kalkan İA, Azap A, et al. Carbapenemase-producing bacterial infections in patients with liver transplant. Transplant Proc. 2019;51(7):2461–2465. doi: 10.1016/j.transproceed.2019.02.050.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim SI, Lee YD, et al. Carbapenem-resistant Acinetobacter baumannii bacteremia in liver transplant recipients. Transplant Proc. 2018;50(4):1132–1135. doi: 10.1016/j.transproceed.2018.01.043.
   PubMed Web of Science ®Google Scholar
• Lee KH, Han SH, Yong D, et al. Acquisition of carbapenemase-producing Enterobacteriaceae in solid organ transplantation recipients. Transplant Proc. 2018;50(10):3748–3755. doi: 10.1016/j.transproceed.2018.01.058.
   PubMed Web of Science ®Google Scholar
• Giannella M, Bartoletti M, Campoli C, et al. The impact of carbapenemase-producing enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Clin Microbiol Infect. 2019;25(12):1525–1531. doi: 10.1016/j.cmi.2019.04.014.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhong J, Ding H, et al. Analysis of risk factors for carbapenem-resistant Klebsiella pneumoniae infection and its effect on the outcome of early infection after kidney transplantation. Front Cell Infect Microbiol. 2021;11:726282. doi: 10.3389/fcimb.2021.726282.
   PubMed Web of Science ®Google Scholar
• Pagani N, Corcione S, Lupia T, et al. Carbapenemase-producing Klebsiella pneumoniae colonization and infection in solid organ transplant recipients: a single-center, retrospective study. Microorganisms. 2021;9(11):2272. doi: 10.3390/microorganisms9112272.
   PubMed Web of Science ®Google Scholar
• Hong Nguyen M, Shields RK, Chen L, et al. Molecular epidemiology, natural history, and long-term outcomes of multidrug-resistant enterobacterales colonization and infections among solid organ transplant recipients. Clin Infect Dis. 2022;74(3):395–406.
   PubMed Web of Science ®Google Scholar
• Kalpoe JS, Sonnenberg E, Factor SH, et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2012;18(4):468–474. doi: 10.1002/lt.23374.
   PubMed Web of Science ®Google Scholar
• Taminato M, Fram D, Pereira RR, et al. Infection related to Klebsiella pneumoniae producing carbapenemase in renal transplant patients. Rev Bras Enferm. 2019;72(3):760–766. doi: 10.1590/0034-7167-2019-0009.
   PubMed Web of Science ®Google Scholar
• Pereira MR, Scully BF, Pouch SM, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015;21(12):1511–1519. doi: 10.1002/lt.24207.
   PubMed Web of Science ®Google Scholar
• Mazza E, Prosperi M, Panzeri MF, et al. Carbapenem-resistant Klebsiella pneumoniae infections early after liver transplantation: a single-center experience. Transplant Proc. 2017;49(4):677–681. doi: 10.1016/j.transproceed.2017.02.028.
   PubMed Web of Science ®Google Scholar
• Giannella M, Bartoletti M, Morelli MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant. 2015;15(6):1708–1715. doi: 10.1111/ajt.13136.
   PubMed Web of Science ®Google Scholar
• Varotti G, Dodi F, Terulla A, et al. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation. Transpl Infect Dis. 2017;19(6):e12757. doi: 10.1111/tid.12757.
   PubMed Web of Science ®Google Scholar
• Wu D, Chen C, Liu T, et al. Risk factors for acquisition of carbapenem-resistant Klebsiella pneumoniae and mortality among abdominal solid organ transplant recipients with K. pneumoniae infections. Med Sci Monit. 2020;26:e922996. doi: 10.12659/MSM.922996.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Montalti R, Castelli P, et al. Carbapenem-resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients. BMC Infect Dis. 2016;16(1):538. doi: 10.1186/s12879-016-1876-5.
   PubMedGoogle Scholar
• Weng L, Hu Y, Sun Z, et al. Place of death and phenomenon of going home to die in Chinese adults: a prospective cohort study. Lancet Reg Health West Pac. 2021;18:100301. doi: 10.1016/j.lanwpc.2021.100301.
   PubMedGoogle Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi: 10.1186/s12941-017-0191-3.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang A, Han L, et al. Clinical outcomes and risk factors for death following carbapenem-resistant Klebsiella pneumoniae infection in solid organ transplant recipients. Microbiol Spectr. 2023;11(1):e0475522. doi: 10.1128/spectrum.04755-22.
   PubMed Web of Science ®Google Scholar
• Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50(3):364–373. doi: 10.1086/649865.
   PubMed Web of Science ®Google Scholar
• Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17(12):1798–1803. doi: 10.1111/j.1469-0691.2011.03514.x.
   PubMed Web of Science ®Google Scholar
• Paño Pardo JR, Serrano Villar S, Ramos Ramos JC, et al. Infections caused by carbapenemase-producing enterobacteriaceae: risk factors, clinical features and prognosis. Enferm Infecc Microbiol Clin. 2014;32(Suppl 4):41–48. doi: 10.1016/S0213-005X(14)70173-9.
   PubMedGoogle Scholar
• Yan L, Sun J, Xu X, et al. Epidemiology and risk factors of rectal colonization of carbapenemase-producing enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital. Antimicrob Resist Infect Control. 2020;9(1):155.
   PubMed Web of Science ®Google Scholar
• Dautzenberg MJ, Wekesa AN, Gniadkowski M, et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med. 2015;43(6):1170–1177. doi: 10.1097/CCM.0000000000001028.
   PubMed Web of Science ®Google Scholar
• Lansdorp B, Hofhuizen C, van Lavieren M, et al. Mechanical ventilation-induced intrathoracic pressure distribution and heart-lung interactions. Crit Care Med. 2014;42(9):1983–1990. doi: 10.1097/CCM.0000000000000345.
   PubMed Web of Science ®Google Scholar
• Zhang J, He Q, Du L, et al. Risk factor for lung infection in recipients after liver transplantation: a meta-analysis. Artif Organs. 2021;45(3):289–296. doi: 10.1111/aor.13826.
   PubMed Web of Science ®Google Scholar
• de Koff EM, Man WH, van Houten MA, et al. The respiratory microbiota during and following mechanical ventilation for respiratory infections in children. Eur Respir J. 2021;57(4):2002652. doi: 10.1183/13993003.02652-2020.
   PubMed Web of Science ®Google Scholar
• Otsuji K, Fukuda K, Ogawa M, et al. Dynamics of microbiota during mechanical ventilation in aspiration pneumonia. BMC Pulm Med. 2019;19(1):260. doi: 10.1186/s12890-019-1021-5.
   PubMed Web of Science ®Google Scholar
• Le Guern R, Grandjean T, Bauduin M, et al. Impact of the timing of antibiotic administration on digestive colonization with carbapenemase-producing Enterobacteriaceae in a murine model. Antimicrob Agents Chemother. 2019;63(6):e00360-19. doi: 10.1128/AAC.00360-19.
   PubMed Web of Science ®Google Scholar
• Li M, Wang X, Wang J, et al. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study. Antimicrob Resist Infect Control. 2019;8(1):8. doi: 10.1186/s13756-018-0453-7.
   PubMedGoogle Scholar
• Dai Y, Meng T, Wang X, et al. Validation and extrapolation of a multimodal infection prevention and control intervention on carbapenem-resistant Klebsiella pneumoniae in an epidemic region: a historical control quasi-experimental study. Front Med. 2021;8:692813. doi: 10.3389/fmed.2021.692813.
   Web of Science ®Google Scholar